Skip to content

Ionis Pharmaceuticals IONS Operating Segments — Operating Income

Discontinued — last reported Q1 '18

Similar metrics at other companies

Linde logo
LINOther — Operating Income (Loss)
-$4M-129%
Martin Marietta Materials logo
MLMReportable Segments — Operating Income
$222M-2.6%
Zillow Group, Inc. logo
ZGReportable Segments — Operating Income (Loss)
$36M+500%
Quest Diagnostics logo
DGXAll other operating segments — Operating Income (Loss)
$7M-12.5%
Target logo
TGTReportable Segment — Operating Income (Loss)
$1.14B-22.9%
MACOM Technology Solutions logo
MTSIReportable Segment — Operating Income (Loss)
$50.83M+45.8%

Other financials

Income statement

See full
Revenue$246.1M+87.0%
Gross profit$243.1M+86.8%
Operating income-$117.4M+20.0%
Net income-$92.5M+37.0%
EPS (diluted)-$0.56+39.8%

Balance sheet

See full
Cash & equivalents$173.4M-34.4%
Total debt$691.7M+334%
Total equity$491.4M+3.3%
Total assets$3.4B+22.6%

Cash flow

See full
Operating cash flow-$792.8M-426%
CapEx$21.8M+73.0%
Free cash flow-$814.6M-399%

Valuation

See full
Market cap$12.25B+159%
Enterprise value$12.77B+175%
P/S11.6×+5.0×

Profitability

See full
Gross margin98.4%-0.2pp
Operating margin-33.3%-11.0pp
Net margin-30.9%-10.5pp
FCF margin-77.4%+35.3pp

Returns & leverage

See full
Return on equity-67.6%-20.3pp
Debt / equity1.4×+1.1×
Current ratio4.1×-5.6×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Ionis Pharmaceuticals’s 10-Q, filed May 7, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does operating segments — operating income mean?
Measures the profitability of a specific operating segment after deducting operating expenses from segment revenue. It serves as a primary indicator of the segment's operational performance and its contribution to the company's overall bottom line. This metric highlights the segment's ability to generate value independently of corporate-level overhead.